immuno-MRM

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

10 months ago Arlette

This acquisition solidifies CellCarta's leadership position in proteomics services with an unique mix of validated set of reagents and multiplex assays, consisting of path...

FDA receives letter of interest (LOI) to test specificity of molecular membrane antibodies as part of ISTAND drug development tool pilot program

3 weeks ago Arlette

ASX Health shares: PromarkerD canagliflozin compared to blood protein canagliflozin is effective

3 weeks ago Arlette

Acrivon Therapeutics announced that the FDA has granted a Fast Track designation for ACR-368 in the platinum-resistant endometrial and ovarian cancer biospace.

3 weeks ago Arlette

FDA approves first RSV vaccine developed by GlaxoSmithKline

1 month ago Arlette

Are women with cancer less active on dating sites

2 months ago Arlette

CellCarta expands it proteomics portfolio with the acquisition of next-generation immuno-MRM assays from Precision Assays

You may have missed

FDA receives letter of interest (LOI) to test specificity of molecular membrane antibodies as part of ISTAND drug development tool pilot program

ASX Health shares: PromarkerD canagliflozin compared to blood protein canagliflozin is effective

Acrivon Therapeutics announced that the FDA has granted a Fast Track designation for ACR-368 in the platinum-resistant endometrial and ovarian cancer biospace.

FDA approves first RSV vaccine developed by GlaxoSmithKline

Are women with cancer less active on dating sites